Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism MMP2 inhibitors(Matrix metalloproteinase-2 inhibitors), PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC22H29NO6S |
InChIKeyLSKDZXBLTZYLIP-KKSFZXQISA-N |
CAS Registry193547-46-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Discovery | United States | - | |
Dermatitis, Atopic | Discovery | United States | - | |
Multiple Sclerosis | Discovery | United States | - | |
Psoriasis | Discovery | United States | - |